Watch Ticker

Beam Therapeutics Inc. Common Stock

Go to Beam Therapeutics Inc. Common Stock Website

$19.04

-0.67 (-3.40%)

Live

Previous Close

$18.83

Day Range

$18.64 - $19.49

Previous Day Range

$19.48 - $20.144

Market Cap

$1.9 billion USD

Day Vol.

2.7 million

Previous Day Vol.

2.4 million

Currency

USD

Primary Exchange

Nasdaq

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases....

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Dan Victor - 10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

Several healthcare and AI-driven companies are demonstrating significant potential in transforming medical technologies, offering innovative therapies and solutions across various medical domains like gene editing, telehealth, and precision medicine.

Related tickers: CERT, BEAM, INSP, PODD, KRYS, LFMD, LFMDP, TEM, TMDX, VEEV.

Read Full Article

Dan Victor - Editas Medicine Is Great. Here's Why You Shouldn't Buy It.

Editas Medicine is a promising clinical-stage biotech company at the forefront of the gene-editing revolution with its unique in vivo CRISPR approach. However, the company faces significant technical challenges, a long road to commercialization, and weak fundamentals, making it a speculative investment.

Related tickers: EDIT, CRSP, BEAM, BMY, CELGr.

Read Full Article

Trending Tickers

Please sign in to view